Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

COVID-19 doesn't make alopecia areata worse.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

Insulin resistance linked to obesity may increase COVID-19 severity.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Anabolic steroid users may face higher risk of severe COVID-19.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Some alopecia treatments might help treat COVID-19, but more research is needed.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

Hair loss doesn't affect COVID-19 severity.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

Lower LDL-c levels predict higher COVID-19 mortality.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.